Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-099600
Filing Date
2010-04-29
Accepted
2010-04-29 17:22:33
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K d10ka.htm 10-K/A 513563
2 SECOND AMENDMENT TO CREDIT AGREEMENT dex103.htm EX-10.3 51116
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 10642
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 10624
5 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4939
  Complete submission text file 0001193125-10-099600.txt   592135
Mailing Address
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
ANGIOTECH PHARMACEUTICALS INC (Filer) CIK: 0001096481 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30334 | Film No.: 10782835
SIC: 3841 Surgical & Medical Instruments & Apparatus